Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Kaminsky · SciRah

Researcher profile · Semantic Scholar

M. Kaminsky

Share profile

M. Kaminsky — researcher profile on SciRah

h-index: 29
Works: 74
Citations: 2,602

Most-cited papers

Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie Digestive Group Study--FFCD 9803.
O. Bouché, J. Raoul, F. Bonnetain, M. Giovannini +12 more
2004Journal of Clinical Oncology279 citations Open access
Semantic Scholar
Phase II study of sunitinib in recurrent or metastatic squamous cell carcinoma of the head and neck: GORTEC 2006-01.
J. Machiels, S. Henry, S. Zanetta, M. Kaminsky +9 more
2010Journal of Clinical Oncology172 citations Open access
Semantic Scholar
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.
Y. Tao, J. Biau, X.-S. Sun, C. Sire +21 more
2022Annals of Oncology154 citations Open access
Semantic Scholar
Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01).
S. Culine, A. Lortholary, J. Voigt, R. Bugat +16 more
2003Journal of Clinical Oncology152 citations
Semantic Scholar
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.
L. Geoffrois, L. Martin, D. de Raucourt, Xu-Shan Sun +28 more
2018Journal of Clinical Oncology131 citations Open access
Semantic Scholar
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
Stefano Kim, E. François, T. André, E. Samalin +23 more
2018The Lancet Oncology125 citations
Semantic Scholar
Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study
C. Reichling, J. Taieb, V. Derangère, Quentin Klopfenstein +17 more
2019Gut104 citations Open access
Semantic Scholar
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.
Xu-Shan Sun, Y. Tao, C. le Tourneau, Y. Pointreau +29 more
2020The Lancet Oncology103 citations
Semantic Scholar
LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial
J. Bourhis, Y. Tao, X. Sun, C. Sire +15 more
2021Annals of Oncology97 citations Open access
Semantic Scholar
A prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors.
S. Atallah, O. Casiraghi, N. Fakhry, M. Wassef +25 more
2020European Journal of Cancer82 citations Open access
Semantic Scholar
Endoscopic surgery reveals that woodworkers' adenocarcinomas originate in the olfactory cleft.
R. Jankowski, T. Georgel, J. Vignaud, B. Hemmaoui +5 more
2007Rhinology75 citations
Semantic Scholar
Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer
L. Uwer, C. Rotonda, F. Guillemin, J. Miny +7 more
2011Health and Quality of Life Outcomes73 citations Open access
Semantic Scholar
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial.
Y. Tao, A. Aupérin, C. Sire, L. Martin +24 more
2018Journal of Clinical Oncology70 citations
Semantic Scholar
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group
P. Heudel, M. Fabbro, C. Roemer-Bécuwe, M. Kaminsky +17 more
2017British Journal of Cancer61 citations Open access
Semantic Scholar
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
Y. Tao, Xu Sun, Y. Pointreau, C. le Tourneau +28 more
2023European Journal of Cancer56 citations Open access
Semantic Scholar
Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins
M. Lapeyre, M. Bollet, S. Racadot, L. Geoffrois +6 more
2004Head and Neck54 citations
Semantic Scholar
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial.
R. Galot, C. le Tourneau, E. Saâda-Bouzid, A. Daste +21 more
2021European Journal of Cancer51 citations Open access
Semantic Scholar
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.
J. Kurtz, M. Kaminsky, A. Floquet, A. Veillard +10 more
2011Annals of Oncology50 citations Open access
Semantic Scholar
Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France.
A. Moya-Plana, A. Aupérin, R. Obongo, A. Baglin +111 more
2019European Journal of Cancer49 citations
Semantic Scholar
Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trial.
M. Gross-Goupil, A. Fourcade, E. Blot, N. Penel +12 more
2012European Journal of Cancer49 citations Open access
Semantic Scholar
Need for Neck Dissection After Radiochemotherapy? A Study of the French GETTEC Group
P. Vedrine, J. Thariat, M. Hitier, F. Janot +5 more
2008The Laryngoscope49 citations
Semantic Scholar
Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.
T. Aparicio, M. Ducreux, R. Faroux, E. Barbier +305 more
2018European Journal of Cancer41 citations Open access
Semantic Scholar
Phase Ib trial of the Toll-like receptor 9 agonist IMO-2055 in combination with 5-fluorouracil, cisplatin, and cetuximab as first-line palliative treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck
J. Machiels, M. Kaminsky, U. Keller, T. Brümmendorf +3 more
2013Investigational new drugs36 citations
Semantic Scholar
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study
Yeh-Chen Lee, M. King, R. O'Connell, A. Lanceley +18 more
2022International Journal of Gynecological Cancer35 citations Open access
Semantic Scholar
A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer.
F. Blanc-Durand, E. Yaniz-Galende, A. Llop-Guevara, C. Genestie +20 more
2023Gynecologic Oncology34 citations Open access
Semantic Scholar
Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases.
L. Dahan, R. Giorgi, S. Vergez, L. Le Taillandier de Gabory +129 more
2020European Journal of Surgical Oncology34 citations Open access
Semantic Scholar
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma
Stefano Kim, A. Meurisse, L. Spehner, M. Stouvenot +24 more
2020Therapeutic Advances in Medical Oncology33 citations Open access
Semantic Scholar
A double-blind phase III trial of immunomodulating nutritional formula during adjuvant chemoradiotherapy in head and neck cancer patients: IMPATOX.
P. Boisselier, M. Kaminsky, S. Thézénas, O. Gallocher +9 more
2020American Journal of Clinical Nutrition33 citations Open access
Semantic Scholar
A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck
J. Machiels, P. Specenier, J. Krauss, Andreas Dietz +10 more
2015Cancer Chemotherapy and Pharmacology33 citations
Semantic Scholar
Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).
F. Roncolato, D. Berton-Rigaud, R. O'Connell, A. Lanceley +15 more
2018Gynecologic Oncology29 citations Open access
Semantic Scholar
Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy.
C. Lee, R. Asher, M. Friedlander, V. Gebski +10 more
2019European Journal of Cancer23 citations
Semantic Scholar
Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study).
Patrick Robelin, M. Tod, O. Colomban, J. Lachuer +17 more
2020Gynecologic Oncology17 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.
G. Ferron, G. de Rauglaudre, S. Becourt, N. Delanoy +28 more
2023Gynecologic Oncology16 citations
Semantic Scholar
Management of patients with head and neck tumours presenting at diagnosis with a synchronous second cancer at another anatomic site.
P. Graff, B. Schipman, Emmanuel Desandes, H. Mecellem +6 more
2011Clinics in oncology16 citations
Semantic Scholar
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era
B. You, L. van Wagensveld, M. Tod, G. Sonke +16 more
2022British Journal of Cancer15 citations Open access
Semantic Scholar
Evaluation of a RAD51 functional assay in advanced ovarian cancer, a GINECO/GINEGEPS study.
F. Blanc-Durand, E. Yaniz, C. Genestie, E. Rouleau +16 more
202115 citations
Semantic Scholar
Impact of adding nintedanib to neoadjuvant chemotherapy (NACT) for advanced epithelial ovarian cancer (EOC) patients: The CHIVA double-blind randomized phase II GINECO study.
G. Ferron, G. de Rauglaudre, A. Chevalier, P. Combe +16 more
2019Journal of Clinical Oncology15 citations
Semantic Scholar
Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French Patients
D. Berton, A. Floquet, W. Lescaut, G. Baron +17 more
2021Frontiers in Pharmacology13 citations Open access
Semantic Scholar
[Standards, Options and Recommendations for the management of patient with carcinoma of unknown primary site].
R. Bugat, A. Bataillard, T. Lesimple, J. Voigt +12 more
2002Bulletin du Cancer12 citations
Semantic Scholar
Sym004, a novel strategy to target EGFR with an antibody mixture, in patients with advanced SCCHN progressing after anti-EGFR monoclonal antibody: A proof of concept study.
J. Machiels, P. Specenier, J. Krauss, A. Dietz +9 more
201311 citations
Semantic Scholar
Afatinib maintenance therapy following post-operative radiochemotherapy in head and neck squamous cell carcinoma: Results from the phase III randomised double-blind placebo-controlled study BIB2992ORL (GORTEC 2010-02).
S. Racadot, Isabelle Thennevet, Yaelle Ouldbey, M. Kaminsky +16 more
2022European Journal of Cancer10 citations Open access
Semantic Scholar
ROCSAN trial (GINECO-EN203b/ENGOT-EN8): A multicentric randomized phase II/III evaluating dostarlimab in combination with niraparib versus niraparib alone compared to chemotherapy in the treatment of endometrial/ovarian carcinosarcoma after at least one line of platinum based chemotherapy.
I. Ray-Coquard, A. Leary, F. Bigot, L. Montané +16 more
202110 citations
Semantic Scholar
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
F. Derquin, A. Floquet, A. Hardy-Bessard, J. Edeline +28 more
2020Gynecologic Oncology10 citations Open access
Semantic Scholar
Phase II study of the PI3K inhibitor BKM120 monotherapy in patients with advanced or recurrent endometrial carcinoma: ENDOPIK, GINECO Study.
P. Heudel, M. Fabbro, C. Roemer-Bécuwe, I. Treilleux +6 more
20159 citations
Semantic Scholar
Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studies.
M. Stouvenot, A. Meurisse, A. Saint, B. Buecher +22 more
2022European Journal of Cancer7 citations Open access
Semantic Scholar
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
J. Thaler, R. Greil, Johannes Gaenzer, W. Eisterer +318 more
2015Annals of Oncology7 citations Open access
Semantic Scholar
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
F. Roncolato, M. King, R. O'Connell, Yeh-Chen Lee +15 more
2024Gynecologic Oncology6 citations Open access
Semantic Scholar
Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial
T. Aparicio, J. Bennouna, K. Le Malicot, V. Boige +16 more
2020British Journal of Cancer6 citations Open access
Semantic Scholar
Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer.
R. Campbell, D. Costa, M. Stockler, Yeh-Chen Lee +18 more
2022Gynecologic Oncology5 citations Open access
Semantic Scholar
The CHIVA study: a GINECO randomized double blind phase II trial of nintedanib versus placebo with the neo-adjuvant chemotherapy (NACT) strategy for patients (pts) with advanced unresectable ovarian cancer (OC). Report of the interval debulking surgery (IDS) safety outcome
G. Ferron, G. de Rauglaudre, I. Ray-Coquard, A. Lesoin +16 more
20165 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Lortholary×13
Invite
A. Lortholary — researcher profile on SciRah
C. Sire×8
Invite
C. Sire — researcher profile on SciRah
L. Geoffrois×8
Invite
L. Geoffrois — researcher profile on SciRah
C. Borel×8
Invite
C. Borel — researcher profile on SciRah

×8

Invite

D. Berton — researcher profile on SciRah

Invite

O. Bouché — researcher profile on SciRah

Invite

Y. Tao — researcher profile on SciRah

Invite

M. Alfonsi — researcher profile on SciRah

Invite

F. Rolland — researcher profile on SciRah

Invite

J. Taieb — researcher profile on SciRah

Invite

F. Joly — researcher profile on SciRah

Invite

L. Martin — researcher profile on SciRah